MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: A multilevel longitudinal analysis in patients with ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 75, Issue 8, 2016, Pages 1486-1493

  Machado, Pedro M ^a,b   Baraliakos, Xenofon ^c   Van Der Heijde, Désirée ^a   Braun, Jürgen ^c,e   Landewé, Robert ^c,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c RHEUMAZENTRUM RUHRGEBIET   (Germany)

^d Amsterdam Rheumatology and Clinical Immunology Center   (Netherlands)

^e Zuyderland Medical Centre   (Netherlands)

Author keywords

Ankylosing Spondylitis; Inflammation; Magnetic Resonance Imaging; Outcomes research; Spondyloarthritis

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CERVICAL SPINE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID STORAGE; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; PRIORITY JOURNAL; VERTEBRA; VERTEBRAL CORNER; ADIPOSE TISSUE; BONE DEVELOPMENT; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE COURSE; DOUBLE BLIND PROCEDURE; MIDDLE AGED; OSTEITIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SPINE; SPONDYLITIS, ANKYLOSING;

ANTIRHEUMATIC AGENT; INFLIXIMAB;

ADIPOSE TISSUE; ADULT; ANTIRHEUMATIC AGENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLIXIMAB; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEITIS; OSTEOGENESIS; RADIOGRAPHY; SPINE; SPONDYLITIS, ANKYLOSING;

EID: 84982840871     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208011     Document Type: Article

References (38)

1. Baraliakos X, Listing J, Rudwaleit M, et al. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 2007;66:910-15.
2. Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: A 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2015;74:52-9.
3. Machado P, Landewé R, Braun J, et al. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis 2010;69:1465-70.
4. Machado P, Landewé R, Braun J, et al. A stratified model for health outcomes in ankylosing spondylitis. Ann Rheum Dis 2011;70:1758-64.
5. Landewé R, Dougados M, Mielants H, et al. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 2009;68:863-7.
6. Sieper J, Appel H, Braun J, et al. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008;58:649-56.
7. Lories RJ, Luyten FP, de Vlam K. Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 2009;11:221.
8. Machado P. Anti-Tumor necrosis factor and new bone formation in ankylosing spondylitis: The controversy continues. Arthritis Rheum 2013;65:2537-40.
9. Hermann KG, Baraliakos X, van der Heijde DM, et al. Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: A consensual approach by the ASAS/OMERACT MRI study group. Ann Rheum Dis 2012;71:1278-88.
10. Lambert RGW, Pedersen SJ, Maksymowych WP, et al. Active inflammatory lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis-definitions, assessment system, and reference image set. J Rheumatol 2009;84:3-17.
11. Østergaard M, Maksymowych WP, Pedersen SJ, et al. Structural lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis-definitions, assessment system, and reference image set. J Rheumatol 2009;84:18-34.
12. stergaard M, Sørensen IJ. Magnetic resonance imaging-key to understanding and monitoring disease progression in spondyloarthritis? J Rheumatol 2015;42:1-4.
13. Mandl P, Navarro-Compán V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015;74:1327-39.
14. Han JS, Kaufman B, El Yousef SJ, et al. NMR imaging of the spine. AJR Am J Roentgenol 1983;141:1137-45.
15. van der Heijde D, Machado P, Braun J, et al. MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: A multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:369-73.
16. Baraliakos X, Listing J, Rudwaleit M, et al. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008;10:R104.
17. Maksymowych WP, Chiowchanwisawakit P, Clare T, et al. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009;60:93-102.
18. Pedersen SJ, Chiowchanwisawakit P, Lambert RG, et al. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J Rheumatol 2011;38:1349-54.
19. Song IH, Hermann KG, Haibel H, et al. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis 2011;70:1257-63.
20. Chiowchanwisawakit P, Lambert RG, Conner-Spady B, et al. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011;63:2215-25.
21. Baraliakos X, Heldmann F, Callhoff J, et al. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-Term observational study using MRI and conventional radiography. Ann Rheum Dis 2014;73:1819-25.
22. Maksymowych WP, Morency N, Conner-Spady B, et al. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis 2013;72:23-8.
23. van der Heijde D, Dijkmans B, Geusens P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005;52:582-91.
24. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
25. Creemers MC, Franssen MJ, vant Hof MA, et al. Assessment of outcome in ankylosing spondylitis: An extended radiographic scoring system. Ann Rheum Dis 2005;64:127-9.
26. Braun J, Landewé R, Hermann KG, et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006;54:1646-52.
27. Twisk JW. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 2004;19:769-76.
28. Machado P, Landewé R, Lie E, et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011;70:47-53.
29. van der Heijde D, Landewé R, Baraliakos X, et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008;58:3063-70.
30. van der Heijde D, Salonen D, Weissman BN, et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009;11:R127.
31. Haroon N, Inman RD, Learch TJ, et al. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013;65:2645-54.
32. Baraliakos X, Haibel H, Listing J, et al. Continuous long-Term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 2014;73:710-5.
33. Zwerina J, Tuerk B, Redlich K, et al. Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis. Arthritis Res Ther 2006;8:R22.
34. Gong Y, Zheng N, Chen SB, et al. Ten years experience with needle biopsy in the early diagnosis of sacroiliitis. Arthritis Rheum 2012;64:1399-406.
35. Wanders A, Heijde D, Landewé R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 2005;52:1756-65.
36. Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 2012; 71:1616-22.
37. Kroon F, Landewé R, Dougados M, et al. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:1623-9.
38. Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012;64:1388-98.